Related Experiment Video
Updated: Jun 8, 2026
09:45
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
Semiconductor-mediated radiosensitizers: progress, challenges and perspectives
Yunsong Wang1,2, Bocan Yang1,2, Shujuan Liu1,2
1School of Materials Science and Engineering, Harbin Institute of Technology, Harbin 150001, P. R. China.
Materials Horizons
|March 4, 2025
Summary
Semiconductor radiosensitizers offer improved cancer treatment by enhancing radiotherapy efficacy. This review explores their principles, strategies for improvement, and future commercialization potential.
Area of Science:
- Nanotechnology
- Materials Science
- Oncology
Background:
- Radiotherapy is crucial for cancer treatment but limited by radiosensitizer sensitivity and side effects.
- Nanotechnology enables novel radiosensitizers with enhanced efficacy.
- Semiconductor radiosensitizers are promising due to their modifiability and multifunctional potential.
Purpose of the Study:
- To provide a systematic review of semiconductor radiosensitizers.
- To elaborate on the principles of semiconductor-induced radiosensitization.
- To discuss strategies for enhancing semiconductor radiosensitivity.
Main Methods:
- Review of existing literature on semiconductor radiosensitizers.
- Analysis of strategies like doping and heterojunction construction.
- Detailed introduction to different types of semiconductor radiosensitizers.
Main Results:
- Semiconductor radiosensitizers demonstrate significant potential for improving radiotherapy.
- Doping and heterojunctions are key strategies to boost radiosensitivity.
- Various semiconductor radiosensitizers have shown promising results.
Conclusions:
- Semiconductor radiosensitizers represent a significant advancement in cancer therapy.
- Further research and development are needed for clinical translation.
- This review offers guidance for the commercial application of these agents.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...